{"id":50921,"date":"2022-11-16T02:02:03","date_gmt":"2022-11-16T01:02:03","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/"},"modified":"2022-11-16T02:02:03","modified_gmt":"2022-11-16T01:02:03","slug":"viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/","title":{"rendered":"Viz.ai partners with Illuminate to improve quality of care for aortic aneurysm patients"},"content":{"rendered":"
\n

\nAdds natural language processing to Viz.ai\u2019s AI-powered platform to detect suspected disease earlier and monitor patients<\/i>\n<\/p>\n

SAN FRANCISCO–(BUSINESS WIRE)–#AI<\/a>—Viz.ai<\/a>, the leader in AI-powered disease detection and intelligent care coordination, today announced a partnership with Illuminate, Inc.<\/a>, an industry leader in the development of proprietary natural language processing (NLP) and AI software that discovers at-risk patients from electronic medical records (EMR), assesses disease severity, and facilitates follow-up surveillance for a variety of diseases. This partnership will enable healthcare providers to make timely, critical decisions for aortic aneurysm patients while improving compliance with pre- and post-surgical surveillance programs.\n<\/p>\n

<\/a><\/p>\n

\n\u201cAortic aneurysm is often called a silent killer with few symptoms before it is too late,\u201d said Jayme Strauss, chief clinical officer at Viz.ai. \u201cWe are excited to collaborate with Illuminate, harnessing the power of AI and NLP to mine insights from EMR data, radiological reports, and imaging studies. This partnership will improve the standard of care for these patients and help healthcare providers coordinate and deliver care at the right time.\u201d\n<\/p>\n

\nAortic aneurysms will often cause no obvious symptoms before a life-threatening rupture occurs, so early detection and monitoring are critical. Illuminate\u2019s NLP capability is a complement to Viz.ai\u2019s growing platform, which will now offer healthcare systems a comprehensive solution to detect more suspected aortic aneurysms earlier and ensure that patients have access to the life-saving treatments or surveillance that they need by cross-functional care teams.\n<\/p>\n

\n\u201cAortic surveillance and screening programs are critical to ensuring that aortic aneurysm patients have their aortic aneurysms detected earlier so they get the care and follow-up that they need. Unfortunately, we have shown that patients often fall through the cracks in the care pathway,\u201d said Dr. Steven Okuhn, chief medical officer at Illuminate and vascular surgeon at the San Francisco VA Medical Center. \u201cThis unique offering will help improve aortic aneurysm detection and patient workflow by bringing together natural language processing and image-based artificial intelligence. I am incredibly excited about this clear advancement in aortic patient care.\u201d\n<\/p>\n

\n\u201cWe are pleased to partner with Viz.ai<\/a> to provide an end-to-end workflow, including follow-up surveillance and disease management, by combining our best-in-class technologies,\u201d said Matt McLenon, CEO of Illuminate. \u201cThis will not only help increase surveillance and compliance and improve patient care but also support faster patient enrollment for clinical research studies.\u201d\n<\/p>\n

\nAbout Viz.ai, Inc.<\/b>\n<\/p>\n

\nViz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care, covering more than 200 million lives across 1,200+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz Platform is an intelligent care coordination solution that identifies more patients with a particular disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by clinical data, the Viz Platform delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information, visit viz.ai<\/a>.\n<\/p>\n

\nAbout Illuminate, Inc.<\/b>\n<\/p>\n

\nIlluminate is the industry leading discovery, follow-up, and patient management company. Combining world class NLP and AI with integrated clinical workflows, the Illuminate Platform allows organizations to deliver the highest quality care throughout a patient\u2019s journey. Illuminate\u2019s mission is to ensure all patients are being managed by the right care team at the right time.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nJoe Duraes
\n
Pazanga Health Communications for Viz.ai
\n
jduraes@pazangahealth.com<\/a>
+1-917-687-6419\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Adds natural language processing to Viz.ai\u2019s AI-powered platform to detect suspected disease earlier and monitor patients SAN FRANCISCO–(BUSINESS WIRE)–#AI—Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a partnership with Illuminate, Inc., an industry leader in the development of proprietary natural language processing (NLP) and AI software that discovers at-risk patients … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50921","6":"format-standard","7":"category-industry"},"yoast_head":"\nViz.ai partners with Illuminate to improve quality of care for aortic aneurysm patients - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Viz.ai partners with Illuminate to improve quality of care for aortic aneurysm patients - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Adds natural language processing to Viz.ai\u2019s AI-powered platform to detect suspected disease earlier and monitor patients SAN FRANCISCO–(BUSINESS WIRE)–#AI—Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a partnership with Illuminate, Inc., an industry leader in the development of proprietary natural language processing (NLP) and AI software that discovers at-risk patients ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-16T01:02:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221115006542\/en\/1639152\/21\/Viz_and_Illuminate_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Viz.ai partners with Illuminate to improve quality of care for aortic aneurysm patients\",\"datePublished\":\"2022-11-16T01:02:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\\\/\"},\"wordCount\":583,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221115006542\\\/en\\\/1639152\\\/21\\\/Viz_and_Illuminate_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\\\/\",\"name\":\"Viz.ai partners with Illuminate to improve quality of care for aortic aneurysm patients - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221115006542\\\/en\\\/1639152\\\/21\\\/Viz_and_Illuminate_logo.jpg\",\"datePublished\":\"2022-11-16T01:02:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221115006542\\\/en\\\/1639152\\\/21\\\/Viz_and_Illuminate_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221115006542\\\/en\\\/1639152\\\/21\\\/Viz_and_Illuminate_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Viz.ai partners with Illuminate to improve quality of care for aortic aneurysm patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Viz.ai partners with Illuminate to improve quality of care for aortic aneurysm patients - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/","og_locale":"en_US","og_type":"article","og_title":"Viz.ai partners with Illuminate to improve quality of care for aortic aneurysm patients - Pharma Trend","og_description":"Adds natural language processing to Viz.ai\u2019s AI-powered platform to detect suspected disease earlier and monitor patients SAN FRANCISCO–(BUSINESS WIRE)–#AI—Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a partnership with Illuminate, Inc., an industry leader in the development of proprietary natural language processing (NLP) and AI software that discovers at-risk patients ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-16T01:02:03+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221115006542\/en\/1639152\/21\/Viz_and_Illuminate_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Viz.ai partners with Illuminate to improve quality of care for aortic aneurysm patients","datePublished":"2022-11-16T01:02:03+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/"},"wordCount":583,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221115006542\/en\/1639152\/21\/Viz_and_Illuminate_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/","url":"https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/","name":"Viz.ai partners with Illuminate to improve quality of care for aortic aneurysm patients - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221115006542\/en\/1639152\/21\/Viz_and_Illuminate_logo.jpg","datePublished":"2022-11-16T01:02:03+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221115006542\/en\/1639152\/21\/Viz_and_Illuminate_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221115006542\/en\/1639152\/21\/Viz_and_Illuminate_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/viz-ai-partners-with-illuminate-to-improve-quality-of-care-for-aortic-aneurysm-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Viz.ai partners with Illuminate to improve quality of care for aortic aneurysm patients"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50921","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50921"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50921\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50921"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50921"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50921"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}